HAEMATO AG proposes dividend payment

Ad hoc of HAEMATO AG pursuant to Art. 17 MAR:

The Supervisory Board of HAEMATO AG approved the Executive Board’s proposal for the appropriation of profits at today’s balance sheet meeting. The Executive Board and Supervisory Board will therefore propose a dividend of EUR 1.00 per dividend-bearing share at the Annual General Meeting to be held on July 13, 2021.

HAEMATO AG, founded in 1993, is a pharmaceutical company. The focus of its business activities is on the trading of high-priced special pharmaceuticals (with a therapeutic focus on cancer, HIV and other chronic diseases) as well as the development and distribution of medical products and own brands, particularly in the field of „aesthetic medicine“.

HAEMATO AG is listed on the Basic Board (Open Market) of the Frankfurt Stock Exchange.

Key figures of the HAEMATO AG share:
Subscribed capital: EUR 5,299,307
Listed share class: Ordinary bearer shares
ISIN: DE000A289VV1
Stock exchange symbol: HAEK

Go back

For investors

Do you have any further questions about the group? Our investor relations team is happy to help you..

Contact us